Application of a macrolide compound in reversing tumor multidrug resistance and enhancing antitumor efficacy
A multi-drug resistance, tumor technology, applied in anti-tumor drugs, medical preparations containing active ingredients, pharmaceutical formulations, etc. complex issues
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Example 1 Compound Con enhances the in vitro antitumor effect of ABCB1 or ABCG2 substrate chemotherapeutic drugs on corresponding drug-resistant cells
[0031] 1.1 Material Description
[0032] Tumor cell lines: human oral cancer cell line KB and its ABCB1 overexpression cell line KBv200, human chronic myeloid leukemia cell line K562 and its ABCB1 overexpression cell line K562 / adr, human breast cancer cell line MCF-7 and its ABCB1 overexpression cell line Cell line MCF-7 / adr, human colon cancer cell line S1 and its ABCG2 overexpressing cell line S1-M1-80, human non-small cell lung cancer cell line H460 and its ABCG2 overexpressing cell line H460 / MX20, human embryonic kidney cancer Cell line HEK293 and its transfection empty vector cell line HEK293 / pcDNA3.1, ABCB1 stable transfection cell line HEK293 / ABCB1, ABCG2 stable transfection cell line HEK293 / ABCG2-R2. KBv200 cells were added with vincristine at a final concentration of 0.2 mg / L in the culture system, and K562 / ad...
Embodiment 2
[0045] Example 2 Compound Con enhances the in vivo antitumor effect of substrate chemotherapeutic drugs on ABCB1-mediated drug-resistant cells
[0046] 2.1 Materials
[0047] Human oral epithelial cancer vincristine-resistant cells KBv200, 5-6 weeks old BALB / C-nu nude mice, no special pathogenic bacteria (SPF) grade, male, purchased from Shanghai Slack Laboratory Animal Co., Ltd., production license License number: SCXK (Shanghai) 2012-0002; Laboratory animal breeding facility use license number: SYXK (Min 2016-0007).
[0048] 2.2 Methods
[0049] 2.2.1 Establishment of nude mouse KBv200 xenograft model
[0050] Collect 1×10 KBv200 cells in logarithmic growth phase 8 / mL, 3 nude mice were taken as breeding mice, and 0.2 mL of cell suspension was injected into each nude mouse subcutaneously in the right forelimb. After the tumor mass is formed, modeling is carried out, and the modeling process is carried out in a sterile operating table. Before modeling, the nude mice were...
Embodiment 3
[0057] Example 3 Compound Con increases intracellular accumulation of the substrate chemotherapeutic drug DOX in ABCB1 or ABCG2 overexpressing cells
[0058] 3.1 Materials
[0059] Human oral cancer cell KB and its ABCB1-overexpressing cell line KBv200, human chronic myeloid leukemia cell line K562 and its ABCB1-overexpressing cell line K562 / adr, human breast cancer cell line MCF-7 and its ABCB1-overexpressing cell line MCF- 7 / adr, human colon cancer cell line S1 and its ABCG2 overexpressing cell line S1-M1-80.
[0060] 3.2 Methods
[0061] Sensitive cell lines KB, K562, MCF-7, S1 in logarithmic growth phase and corresponding drug-resistant cell lines KBv200, K562 / adr, MCF-7 / adr, S1-M1-80 (600,000 / well) were inoculated into Six-well plate; 0 and 1 / 4 IC were added after culturing for 24 hours. 10 , 1 / 2IC 10 , IC 10 Different final concentrations of Con or 10 μM VPR, 2.5 μM Ko134 culture medium; after incubation at 37°C for 3 h, doxorubicin (10 μM) was added to incubate for...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com